Daiichi Sankyo U.S. CEO Joe Pieroni: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Exec discusses the merger of Daiichi and Sankyo, how the combined entity has evolved, and how the firm's Benicar/amlodipine combination Azor figures as a key growth driver going forward.